Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lactoferrin - Pharming

Next Previous
Drug Profile

Lactoferrin - Pharming

Alternative Names: GPX 400; hLF

Latest Information Update: 11 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharming Group NV
  • Class Adjuvants; Antibacterials; Antifungals; Glycoproteins; Iron binding proteins
  • Mechanism of Action Chelating agents; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma; Bacterial infections; Cardiovascular disorders; Eye disorders; Haemorrhage; Hepatitis C

Most Recent Events

  • 08 Mar 2005 Pharming and ProBio and Infigen have entered into an agreement for lactoferrin
  • 28 Oct 2003 Lactoferrin is no longer licensed to AM-Pharma Holding
  • 31 Mar 2003 Pharming has developed a focussed strategy for further development of its lactoferrin product that will be pursued through strategic partnerships with interested parties. As such, the product is available for licensing (http://pharming.com)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top